SpineGuard Announces Its Full-year 2022 Financial Results and Its First Quarter 2023 Sales
Sales of €5.6 million, up 27% and EBITDA improved by 17% in 2022 Increased investments in innovation for the US business Cash runway over 24 months 1Q23 sales growing 12% Regulatory
United States France General Imagerie Biom Mathilde Bohin Pierre Laurent Alain Vanquaethem Maurice Bourlion
Source: finanznachrichten.de